S Zeuzem

1.3k total citations
42 papers, 933 citations indexed

About

S Zeuzem is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S Zeuzem has authored 42 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 25 papers in Epidemiology and 7 papers in Infectious Diseases. Recurrent topics in S Zeuzem's work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (14 papers). S Zeuzem is often cited by papers focused on Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (15 papers) and Liver Disease Diagnosis and Treatment (14 papers). S Zeuzem collaborates with scholars based in Germany, United States and France. S Zeuzem's co-authors include Christoph Sarrazin, Christian M. Lange, Thomas Berg, Eva Herrmann, U. Hopf, Bertram Wiedenmann, Roman Zachoval, Holger Hinrichsen, Tilman Gerlach and Albrecht Piiper and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

S Zeuzem

33 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Zeuzem Germany 11 788 740 115 108 84 42 933
Kelly Kaita Canada 19 756 1.0× 887 1.2× 97 0.8× 111 1.0× 56 0.7× 49 1.2k
Thomas–Matthias Scherzer Austria 12 625 0.8× 625 0.8× 55 0.5× 77 0.7× 75 0.9× 16 884
Etsuko Iio Japan 17 584 0.7× 626 0.8× 144 1.3× 190 1.8× 53 0.6× 52 842
Ana Carolina Cardoso Brazil 16 798 1.0× 905 1.2× 61 0.5× 45 0.4× 41 0.5× 31 1.0k
Alan Polito United States 14 541 0.7× 452 0.6× 86 0.7× 151 1.4× 90 1.1× 18 809
Yukio Gibo Japan 10 1.2k 1.6× 1.1k 1.6× 82 0.7× 94 0.9× 116 1.4× 38 1.5k
Diego Flichman Argentina 18 600 0.8× 1.1k 1.5× 150 1.3× 391 3.6× 30 0.4× 71 1.5k
Jacek Juszczyk Poland 12 332 0.4× 334 0.5× 66 0.6× 61 0.6× 34 0.4× 54 495
Marı́a-Pilar Civeira Spain 11 468 0.6× 400 0.5× 32 0.3× 104 1.0× 68 0.8× 13 674
Suman Verma United Kingdom 11 702 0.9× 758 1.0× 49 0.4× 136 1.3× 27 0.3× 28 1.2k

Countries citing papers authored by S Zeuzem

Since Specialization
Citations

This map shows the geographic impact of S Zeuzem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Zeuzem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Zeuzem more than expected).

Fields of papers citing papers by S Zeuzem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Zeuzem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Zeuzem. The network helps show where S Zeuzem may publish in the future.

Co-authorship network of co-authors of S Zeuzem

This figure shows the co-authorship network connecting the top 25 collaborators of S Zeuzem. A scholar is included among the top collaborators of S Zeuzem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Zeuzem. S Zeuzem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tyc, Olaf, Hans‐Peter Erasmus, Cristina Ortiz, et al.. (2025). Enterococcus faecium DNA in acute decompensated cirrhosis: a key player in inflammation and kidney dysfunction. Frontiers in Medicine. 12. 1629210–1629210.
2.
Petroff, David, Jörn M. Schattenberg, S Zeuzem, et al.. (2025). Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry. Zeitschrift für Gastroenterologie. 63(8). 836–843. 1 indexed citations
3.
Henle, Gertrude, et al.. (2024). Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue. International Journal of Molecular Sciences. 25(24). 13521–13521. 1 indexed citations
4.
Erasmus, Hans‐Peter, Alica Kubesch, Mate Knabe, et al.. (2024). A novel ultrasound-based algorithm for the detection of pancreatic stents placed for prophylaxis of post-ERCP pancreatitis: a prospective trial. Ultraschall in der Medizin - European Journal of Ultrasound. 46(2). 177–185.
5.
Uschner, Frank Erhard, Martin Schulz, Olaf Tyc, et al.. (2021). SAFETY AND PRELIMINARY EFFICACY AND PHARMACOKINETICS OF INTRAPERITONEAL VS-01 INFUSIONS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1b CLINICAL TRIAL. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
6.
Sprinzl, Kathrin, Johannes Vermehren, Annette Grambihler, et al.. (2017). Hepatitis B patients under oral nucleos(t)ide treatment with intermittent kidney function assessment (The BONIKA-study) – a multicenter, prospective, observational trial (NCT-Nr. 02267473). Journal of Hepatology. 66(1). S477–S477. 1 indexed citations
7.
Deuffic‐Burban, Sylvie, Pierre Deltenre, Marı́a Buti, et al.. (2011). 122 HCV BURDEN IN EUROPE: IMPACT OF NATIONAL TREATMENT PRACTICES ON FUTURE HCV-RELATED MORBIDITY AND MORTALITY THROUGH A MODELING APPROACH. Journal of Hepatology. 54. S54–S54. 6 indexed citations
8.
Lange, Christian M., Christoph Sarrazin, & S Zeuzem. (2010). Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy. Alimentary Pharmacology & Therapeutics. 32(1). 14–28. 86 indexed citations
9.
Gorfine, Malka, L. S. Freedman, Jean–Michel Pawlotsky, et al.. (2009). Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment. Journal of Viral Hepatitis. 17(5). 345–351. 4 indexed citations
10.
Zeuzem, S & W. F. Caspary. (2008). Diagnostik der autonomen diabetischen Neuropathie des Gastrointestinaltrakts*. DMW - Deutsche Medizinische Wochenschrift. 117(34). 1285–1289.
11.
Schröder, Oliver, Ju Hee Lee, G. Herrmann, H. Rabenau, & S Zeuzem. (2008). Schwere akute cholestatische Virushepatitis E bei einer nicht-schwangeren Patientin. DMW - Deutsche Medizinische Wochenschrift. 122(01/02). 21–24. 2 indexed citations
12.
13.
14.
Zeuzem, S. (2003). Combination therapy for chronic hepatitis C. DMW - Deutsche Medizinische Wochenschrift. 128(8). 370–374.
15.
Berg, Thomas, Eva Herrmann, Holger Hinrichsen, et al.. (2003). Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During Therapy. Hepatology. 37(3). 600–609. 221 indexed citations
16.
Zeuzem, S. (2001). THE KINETICS OF HEPATITIS C VIRUS INFECTION. Clinics in Liver Disease. 5(4). 917–930. 15 indexed citations
17.
Zeuzem, S. (2000). Gut-liver axis. International Journal of Colorectal Disease. 15(2). 59–82. 86 indexed citations
18.
Zeuzem, S, et al.. (1996). Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients. Kidney International. 49(3). 896–902. 35 indexed citations
19.
Milović, Vladan, et al.. (1995). EGF Stimulates Polyamine Uptake in Caco-2 Cells. Biochemical and Biophysical Research Communications. 206(3). 962–968. 33 indexed citations
20.
Stein, Jürgen M., et al.. (1994). Preparation of basolateral membrane vesicles from rat enterocytes: influence of different gradient media.. PubMed. 43(2). 75–81. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly Kaita Breakdown of academic impact, for papers by Thomas–Matthias Scherzer Breakdown of academic impact, for papers by Etsuko Iio Breakdown of academic impact, for papers by Ana Carolina Cardoso Breakdown of academic impact, for papers by Alan Polito Breakdown of academic impact, for papers by Yukio Gibo Breakdown of academic impact, for papers by Diego Flichman Breakdown of academic impact, for papers by Jacek Juszczyk Breakdown of academic impact, for papers by Marı́a-Pilar Civeira Breakdown of academic impact, for papers by Suman Verma
Rankless by CCL
2026